Publications by authors named "Jean DePamphilis"

Claim this Profile
I
Induction dosing of peginterferon alfa-2a (40 KD) and/or high-dose ribavirin in genotype 1 CHC patients with difficult-to-treat characteristics: pharmacokinetic and viral kinetic (PK/VK) assessment from PROGRESS.
Peter N Morcos, Ruby Leong, James A Thommes, Jean DePamphilis, Joseph F Grippo

Hepatogastroenterology· June 2015

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
V
Virological response is associated with decline in hemoglobin concentration during pegylated interferon and ribavirin therapy in hepatitis C virus genotype 1.
William Sievert, Gregory J Dore, Geoffrey W McCaughan, Motoko Yoshihara, Darrell H Crawford, Jean K Depamphilis

Hepatology· April 2011

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
I
Impact of high-dose peginterferon alfa-2A on virological response rates in patients with hepatitis C genotype 1: a randomized controlled trial.
Stuart K Roberts, Martin D Weltman, Darrell H G Crawford, Geoffrey W McCaughan, William Sievert, Jean K Depamphilis

Hepatology· October 2009

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Hepatic steatosis in HIV/HCV co-infected patients: correlates, efficacy and outcomes of anti-HCV therapy: a paired liver biopsy study.
Maribel Rodríguez-Torres, Sugantha Govindarajan, Ricard Solá, Nathan Clumeck, Eduardo Lissen, Jean Depamphilis

J Hepatol· May 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
E
Effect of baseline CD4 cell count on the efficacy and safety of peginterferon Alfa-2a (40KD) plus ribavirin in patients with HIV/hepatitis C virus coinfection.
Milos Opravil, Joe Sasadeusz, David A Cooper, Jürgen K Rockstroh, Nathan Clumeck, Jean Depamphilis

J Acquir Immune Defic Syndr· January 2008

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
H
Histological response to pegIFNalpha-2a (40KD) plus ribavirin in HIV-hepatitis C virus co-infection.
Eduardo Lissen, Nathan Clumeck, Ricardo Sola, Maria Mendes-Correa, Julio Montaner, Jean DePamphilis

AIDS· November 2006

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis
R
Risk factors for hepatic decompensation in patients with HIV/HCV coinfection and liver cirrhosis during interferon-based therapy.
Stefan Mauss, William Valenti, Jean DePamphilis, Frank Duff, Lisa Cupelli

AIDS· September 2004

Social Media Activity not collected for this article yet.

Sign Up to Request Social Media Analysis